Suppr超能文献

5-羟色胺(7)受体的失活部分阻断了苯环利定诱导的前脉冲抑制破坏。

Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.

作者信息

Semenova Svetlana, Geyer Mark A, Sutcliffe J Gregor, Markou Athina, Hedlund Peter B

机构信息

Department of Psychiatry, University of California, San Diego, USA.

出版信息

Biol Psychiatry. 2008 Jan 1;63(1):98-105. doi: 10.1016/j.biopsych.2006.12.011. Epub 2007 May 24.

Abstract

BACKGROUND

Studies have implicated the serotonin (5-HT)(7) receptor in physiological and pathophysiological phenomena, including thermoregulation, central control of micturition and locomotion, regulation of circadian rhythm, sleep, and depression. Further, several antidepressant and antipsychotic drugs have high affinity for the 5-HT(7) receptor.

METHODS

We examined the role of 5-HT(7) receptors in a rodent analogue of sensorimotor gating deficits in schizophrenia: phencyclidine (PCP)-induced disruption of prepulse inhibition (PPI) of acoustic startle. We used mice lacking the 5-HT(7) receptor due to a targeted inactivation of this receptor gene and the selective 5-HT(7) receptor antagonist SB-269970.

RESULTS

SB-269970 did not affect either baseline PPI or PCP-disrupted PPI. There was no difference between 5-HT(7)(+/+) and 5-HT(7)(-/-) mice in startle reactivity or PPI regardless of prepulse intensity (74-82 dB), interstimulus interval (25-500 msec), or pulse intensity (90-120 dB). Nevertheless, disruption of PPI produced by PCP (10 mg/kg) in wild-type mice was reduced in 5-HT(7)(-/-) mice, although it was not affected by the 5-HT(7) antagonist SB-269970. By contrast, the PPI-disruptive effects of apomorphine (5 mg/kg) and amphetamine (7.5 mg/kg) were comparable in both genotypes.

CONCLUSIONS

The results indicate a partial role for the 5-HT(7) receptor in the glutamatergic PPI model of sensorimotor gating deficits in schizophrenia that is sensitive to atypical antipsychotics and no involvement of this receptor in the dopaminergic PPI model that is sensitive to typical antipsychotics. Thus, the 5-HT(7)(-/-) mice may provide a useful tool to study the role of 5-HT(7) receptor in the action of atypical antipsychotic drugs and schizophrenia.

摘要

背景

研究表明,血清素(5-羟色胺,5-HT)(7)受体参与了多种生理和病理生理现象,包括体温调节、排尿和运动的中枢控制、昼夜节律调节、睡眠及抑郁。此外,几种抗抑郁药和抗精神病药对5-HT(7)受体具有高亲和力。

方法

我们在啮齿动物模型中研究了5-HT(7)受体在精神分裂症感觉运动门控缺陷中的作用:苯环利定(PCP)诱导的听觉惊吓前脉冲抑制(PPI)破坏。我们使用了因该受体基因靶向失活而缺乏5-HT(7)受体的小鼠以及选择性5-HT(7)受体拮抗剂SB-269970。

结果

SB-269970对基线PPI或PCP破坏的PPI均无影响。无论前脉冲强度(74 - 82分贝)、刺激间隔(25 - 500毫秒)或脉冲强度(90 - 120分贝)如何,5-HT(7)(+/+)和5-HT(7)(-/-)小鼠在惊吓反应性或PPI方面均无差异。然而,野生型小鼠中由PCP(10毫克/千克)产生的PPI破坏在5-HT(7)(-/-)小鼠中有所减轻,尽管它不受5-HT(7)拮抗剂SB-269970的影响。相比之下,阿扑吗啡(5毫克/千克)和苯丙胺(7.5毫克/千克)对PPI的破坏作用在两种基因型中相当。

结论

结果表明,5-HT(7)受体在对非典型抗精神病药敏感的精神分裂症感觉运动门控缺陷的谷氨酸能PPI模型中起部分作用,而该受体不参与对典型抗精神病药敏感的多巴胺能PPI模型。因此,5-HT(7)(-/-)小鼠可能为研究5-HT(7)受体在非典型抗精神病药物作用及精神分裂症中的作用提供有用工具。

相似文献

1
Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition.
Biol Psychiatry. 2008 Jan 1;63(1):98-105. doi: 10.1016/j.biopsych.2006.12.011. Epub 2007 May 24.
3
Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
Psychopharmacology (Berl). 2003 Sep;169(3-4):234-9. doi: 10.1007/s00213-003-1533-8. Epub 2003 Jul 4.
9
"Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits.
Neuropsychopharmacology. 2000 Nov;23(5):517-27. doi: 10.1016/S0893-133X(00)00147-0.

引用本文的文献

1
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation.
Int J Mol Sci. 2023 Jan 20;24(3):2070. doi: 10.3390/ijms24032070.
2
5-HT Receptors and the Development of New Antidepressants.
Int J Mol Sci. 2021 Aug 20;22(16):9015. doi: 10.3390/ijms22169015.
4
Effect of a 5-HT7 Receptor Antagonist on Reversal Learning in the Rat Attentional Set-Shifting Test.
ACS Chem Neurosci. 2021 Jan 6;12(1):42-48. doi: 10.1021/acschemneuro.0c00554. Epub 2020 Dec 18.
6
Low-basicity 5-HT Receptor Agonists Synthesized Using the van Leusen Multicomponent Protocol.
Sci Rep. 2017 May 4;7(1):1444. doi: 10.1038/s41598-017-00822-4.
7
Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders.
Mol Psychiatry. 2015 Oct;20(10):1161-72. doi: 10.1038/mp.2015.113. Epub 2015 Aug 11.

本文引用的文献

1
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Neuropharmacology. 2006 Sep;51(3):578-86. doi: 10.1016/j.neuropharm.2006.04.017. Epub 2006 Jul 7.
2
Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population.
Neuropsychopharmacology. 2006 Apr;31(4):866-71. doi: 10.1038/sj.npp.1300901.
3
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern.
Biol Psychiatry. 2005 Nov 15;58(10):831-7. doi: 10.1016/j.biopsych.2005.05.012. Epub 2005 Jul 14.
4
Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression.
Neuropharmacology. 2005 Mar;48(4):492-502. doi: 10.1016/j.neuropharm.2004.11.015.
5
Functional, molecular and pharmacological advances in 5-HT7 receptor research.
Trends Pharmacol Sci. 2004 Sep;25(9):481-6. doi: 10.1016/j.tips.2004.07.002.
7
GABAergic modulation of 5-HT7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus.
Neuropharmacology. 2004 Jun;46(7):935-41. doi: 10.1016/j.neuropharm.2004.01.010.
8
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
Eur J Pharmacol. 2004 Mar 8;487(1-3):125-32. doi: 10.1016/j.ejphar.2004.01.031.
9
5-HT7 receptors.
Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):81-90. doi: 10.2174/1568007043482633.
10
Animal behavior models of the mechanisms underlying antipsychotic atypicality.
Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1071-9. doi: 10.1016/j.pnpbp.2003.09.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验